Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NON INTERVENTIONAL MULTICENTER STUDY, FOR THE VALIDATION OF MOLECULAR DIAGNOSTIC TECHNOLOGIES IN SUBJECTS WITH NON SMALL CELL LUNG CANCER (NSCLC) PROTOCOL N° X9001083

NCT03220230 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03220230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03220230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NON INTERVENTIONAL MULTICENTER STUDY, FOR THE VALIDATION OF MOLECULAR DIAGNOSTIC TECHNOLOGIES IN SUBJECTS WITH NON SMALL CELL LUNG CANCER (NSCLC) PROTOCOL N° X9001083
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 6, 2015
Completion date
October 30, 2018
Enrollment
4,240 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasms